Flu vaccine offered poor protection for seniors this year, CDC says

This season's influenza vaccine was largely ineffective for seniors, according to Centers for Disease Control and Prevention numbers released Thursday.

The flu vaccine was effective for only 9% of those 65 and older, as measured by a survey of nearly 2,700 adults and children undertaken between Dec. 3 and Jan. 19. This means the vaccine prevented a “statistically insignificant” number of seniors from needing outpatient medical attention for the flu, according to the CDC. Overall, the shot was 56% effective for all age groups over six months old.

Seniors generally are more severely affected by the flu and often are less responsive to vaccines than younger people. However, the flu-related death rate for seniors reached extremely high levels this year. The vaccine may have been ineffective because seniors did not respond to its influenza A (H3N2) component, the CDC stated. The vaccine was 67% effective in protecting seniors against influenza B.

The findings are interim, and the CDC plans further research to see if chronic medical conditions or other factors played a part in the vaccine's ineffectiveness among seniors. The flu shot's effectiveness has varied from year to year, so these findings should not be seen as discrediting the need for the vaccine, CDC officials stressed.

More in News

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in ...

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more ...

Long-term care providers should follow hospitals in adopting EHRs, government says ...

Healthcare providers have already exceeded the government's 2013 adoption goals for electronic health records, the Department of Health and Human Services announced Wednesday.

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.